Champions Oncology Inc (CSBR)

[Milburn D]

Don't know if this will help you, but here is a crude translation of the first 1000 characters, via the website

http://imtranslator.net/translation/hebrew/to-english/translation/

Champions Corporation U.S. Oncology, which develops customized treatments for cancer and is traded NASDAQ Jack (Bulletin Board list) a market value of $ 32 million, establishing a spin - off Israel in the field of drug development under the name Peak - BIO (C-Bio). Learned to Globes.

This move is a novelty: no American pharmaceutical company in Israel has not established a drug development division independently, without having committed any purchase. On - the layout of the spin transaction - Oh, Champions will hold only minority shares in the company - Israeli subsidiary, joined the first phase about 3-4 million.

Champions, established - by the acclaimed cancer researcher Professor David Sidrnsky, started out providing VIP services to cancer patients. Below, has developed capabilities in classification of cancers and matching treatments to patient. Based on these capabilities is identified several new drugs, she assumed they have the potential to be very successful and effective targeted therapy of cancer of various types.

These drugs will spin - off the new, headed by Guy Malchi, Until recently Head of Pharma Division Champions.

Also due to the support scientist

Champions of the relationship with Israel and Zionism derives in part of Sidrnsky, who currently resides in the framework of...